Skip to main content

Table 5 Multivariable logistic regressive analysis: risk factors for flare in SQCQ

From: Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study

  β p OR (95% CI)
Taking antimalarials when relapsed or at the end of follow-up − 3.584 0.033 0.028 (0.001, 0.743)
  1. Variables included in the model: age at diagnosis (years), dose of corticosteroids (mg) when relapsed or at the end of follow-up, taking antimalarials when relapsed or at the end of follow-up, taking immunosuppressants when relapsed or at the end of follow-up, duration of serological inactivity before SQCQ (months)